Zhipeng Wang
A5090880378- Epigenetics and DNA Methylation
- Renal cell carcinoma treatment
- Phagocytosis and Immune Regulation
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Urologic and reproductive health conditions
- Cancer-related molecular mechanisms research
- RNA modifications and cancer
- Histiocytic Disorders and Treatments
- Ubiquitin and proteasome pathways
- Eosinophilic Disorders and Syndromes
- Nanoparticle-Based Drug Delivery
- Biofuel production and bioconversion
- Ovarian cancer diagnosis and treatment
- Histone Deacetylase Inhibitors Research
- Genetic factors in colorectal cancer
- RNA Interference and Gene Delivery
- Cancer Genomics and Diagnostics
- Parvovirus B19 Infection Studies
- Catalysis for Biomass Conversion
- Lignin and Wood Chemistry
- Protein Degradation and Inhibitors
China West Normal University
2024
Sichuan University
2023-2024
Dalian National Laboratory for Clean Energy
2024
Dalian Institute of Chemical Physics
2024
Chinese Academy of Sciences
2024
University of Greenwich
2022
Soochow University
2022
Jinan University
2022
Guangdong Medical College
2022
University of Göttingen
2022
Abstract Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early divergent, late...
Abstract Purpose: Fumarate hydratase–deficient renal cell carcinoma (FH-deficient RCC) is a rare and lethal subtype of kidney cancer. However, the optimal treatments molecular correlates benefits for FH-deficient RCC are currently lacking. Experimental Design: A total 91 patients with from 15 medical centers between 2009 2022 were enrolled in this study. Genomic bulk RNA-sequencing (RNA-seq) performed on 88 45 untreated RCCs, respectively. Single-cell RNA-seq was to identify biomarkers...
<p>Table S6</p>
<p>Table S4</p>
<p>Table S3</p>
<p>Supplementary Methods</p>
<p>Table S4</p>
<p>Table S1-revised</p>
<p>Supplementary Methods</p>
<p>Table S5</p>
<div>Abstract<p>Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early...
<p>Table S7</p>
<div>Abstract<p>Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early...
<p>Supplementary figure 1-15</p>
<p>Table S8</p>
<p>Supplementary figure 1-15</p>
<p>Table S5</p>
<p>Table S1-revised</p>
<p>Table S6</p>
<p>Table S2-revised</p>
<p>Table S8</p>
<p>Table S2-revised</p>
<p>Table S3</p>